P-9.0001, r. 0.1 - Regulation respecting the application of the Act respecting the sharing of certain health information

Updated to 29 January 2019

This document has official status.

not in force

chapter P-9.0001, r. 0.1

Regulation respecting the application of the Act respecting the sharing of certain health information

Act respecting the sharing of certain health information

(chapter P 9.0001, ss. 4, par. 20, 24, 26, par. 18, 44, par. 4, 69, par. 16, and 120, pars. 1, 2 and 4).

1. In addition to the persons and partnerships provided for in section 4 of the Act respecting the sharing of certain health information (chapter P-9.0001), the specific information management rules apply to the following persons and partnerships:

(1)  a person or a partnership that operates a private dental office;

(2)  the Institut national de santé publique du Québec;

(3)  Transplant Québec.

O.C. 56-2019, s. 1.

2. Within the meaning of this Regulation, private dental office means a consulting room or office, situated elsewhere than in a facility maintained by an institution, in which one or more dentists, individually or as a group, regularly practise their profession, privately and solely on their own account, without directly or indirectly providing their patients with lodging.

O.C. 56-2019, s. 2.

3. For the purposes of section 24 of the Act, the health information that must be released is the information concerning any medication dispensed and administered to a person in a facility maintained by an institution as part of medical oncology services that the person receives.

O.C. 56-2019, s. 3.

4. In addition to the information provided for in section 26 of the Act, the medication domain is made up of the following health information, if available:

(1)  the date of administration of the medication;

(2)  the name of the department and service where the medication was dispensed and administered;

(3)  the name of the medication in research protocol in the case of such medication;

(4)  the name of the medication in Health Canada’s Special Access Programme for Drugs in the case of such medication.

O.C. 56-2019, s. 4.

5. In addition to the information provided for in section 44 of the Act, the hospitalization domain is made up of the following health information, if available:

(1)  the date on which the person concerned was admitted to the location where services are provided and where the person is hospitalized;

(2)  diagnoses concomitant with the main diagnosis and chronic diseases that have no impact on the taking in charge during hospitalization;

(3)  the indication that a transfusion of blood products or products derived from blood products was performed;

(4)  the date of each of the consultations carried out by a physician during the hospitalization and the specialty of each of those physicians;

(5)  the fact that the hospitalization is part of a research protocol;

(6)  the departure date of the person concerned from the location where services are provided and where the person was hospitalized;

(7)  the medications that the person concerned should be taking after the person’s departure, their dosage, the duration of the treatment and the medications that the person should cease to take;

(8)  a summary comparing the medications prescribed at the time of departure of the person concerned with the medications that the person was taking before being admitted;

(9)  the place towards which the person concerned was directed on the departure date, that is, the person’s domicile with or without service or another institution;

(10)  the various recommendations and follow-ups related to the health problems presented by the patient on the departure date;

(11)  the additional notes on the hospitalization, that is, the notes written upon departure of the person concerned and relating the highlights that occurred during the hospitalization;

(12)  the name and unique provider number of the health professional responsible for the hospitalization;

(13)  the date and cause of death of the person concerned;

(14)  the indication that an autopsy was performed;

(15)  the registration number of the hospitalization summary sheet.

O.C. 56-2019, s. 5.

6. In addition to the providers provided for in section 69 of the Act, the following providers may be assigned an access authorization for a health information bank in a clinical domain or an electronic prescription management system for medication:

(1)  a dentist practising in a private dental office, in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(2)  a dietitian or a nutritionist practising in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(3)  a physiotherapist practising in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(4)  a physical rehabilitation therapist practising in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(5)  a respiratory therapist practising in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(6)  an occupational therapist practising in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(7)  a medical imaging technologist, a radiation oncology technologist or a medical electrophysiology technologist practising in a centre operated by an institution, in a private physician’s office, a specialized medical centre, a medical imaging laboratory or a medical diagnostic radiology laboratory,

(8)  a laboratory technologist practising in a centre operated by an institution, in a private physician’s office, a specialized medical centre or a medical biology laboratory;

(9)  a social worker practising in a centre operated by an institution, in a private physician’s office or a specialized medical centre;

(10)  a nurse practising at Transplant Québec, in the Laboratoire de santé publique du Québec or the Centre de toxicologie du Québec administered by the Institut national de santé publique du Québec;

(11)  a pharmacist practising in a private physician’s office or a specialized medical centre;

(12)  a physician practising in the Laboratoire de santé publique du Québec or the Centre de toxicologie du Québec administered by the Institut national de santé publique du Québec;

(13)  a biochemist or a microbiologist practising or working in the Laboratoire de santé publique du Québec or in the Centre de toxicologie du Québec administered by the Institut national de santé publique du Québec.

O.C. 56-2019, s. 6.

7. (Omitted).

O.C. 56-2019, s. 7.

REFERENCES

O.C. 56-2019, 2019 G.O. 2, 160